1050 related articles for article (PubMed ID: 17377079)
21. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation.
Zemljic G; Bunc M; Yazdanbakhsh AP; Vrtovec B
J Card Fail; 2007 Aug; 13(6):417-21. PubMed ID: 17675054
[TBL] [Abstract][Full Text] [Related]
22. Milrinone, not epinephrine, improves left ventricular compliance after cardiopulmonary bypass.
Lobato EB; Gravenstein N; Martin TD
J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):374-7. PubMed ID: 10972599
[TBL] [Abstract][Full Text] [Related]
23. Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone.
Rieg AD; Schroth SC; Grottke O; Hein M; Ackermann D; Rossaint R; Schälte G
Eur J Anaesthesiol; 2009 Nov; 26(11):946-53. PubMed ID: 19687740
[TBL] [Abstract][Full Text] [Related]
24. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
Ponschab M; Hochmair N; Ghazwinian N; Mueller T; Plöchl W
Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of intravenous milrinone in left ventricular restoration.
Yamaguchi A; Tanaka M; Naito K; Kimura C; Kobinata T; Okamura H; Ino T; Adachi H
Ann Thorac Cardiovasc Surg; 2009 Aug; 15(4):233-8. PubMed ID: 19763054
[TBL] [Abstract][Full Text] [Related]
26. Experiences of levosimendan as an inotropic agent in conjunction with passive containment surgery.
Bredin F; Franco-Cereceda A
Scand Cardiovasc J; 2007 Jun; 41(3):197-200. PubMed ID: 17487771
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery.
Feneck RO; Sherry KM; Withington PS; Oduro-Dominah A;
J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):306-15. PubMed ID: 11426360
[TBL] [Abstract][Full Text] [Related]
28. Timing of levosimendan in cardiac surgery.
Aksun M; Karahan N; Adanir T; Aran G; Yetkin U; Oztürk T; Sencan A; Ozgürbüz U; Gürbüz A
Anadolu Kardiyol Derg; 2009 Jun; 9(3):223-30. PubMed ID: 19520657
[TBL] [Abstract][Full Text] [Related]
29. Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: comparison of patients with a low and high prebypass cardiac index.
Yamada T; Takeda J; Katori N; Tsuzaki K; Ochiai R
J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):367-73. PubMed ID: 10972598
[TBL] [Abstract][Full Text] [Related]
30. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
Oner E; Erturk M; Birant A; Kurtar Mansıroglu A; Akturk IF; Karakurt H; Yalcin AA; Uzun F; Somuncu MU; Yildirim A
Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511
[TBL] [Abstract][Full Text] [Related]
31. New positive inotropic agents in the treatment of left ventricular dysfunction.
De Luca L; Proietti P; Palombaro GL; Battagliese A; Celotto A; Bucciarelli Ducci C; Fedele F
Ital Heart J; 2004 Jun; 5 Suppl 6():63S-67S. PubMed ID: 15185917
[TBL] [Abstract][Full Text] [Related]
32. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery.
Tritapepe L; De Santis V; Vitale D; Guarracino F; Pellegrini F; Pietropaoli P; Singer M
Br J Anaesth; 2009 Feb; 102(2):198-204. PubMed ID: 19151048
[TBL] [Abstract][Full Text] [Related]
33. Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure.
Segreti JA; Marsh KC; Polakowski JS; Fryer RM
J Pharmacol Exp Ther; 2008 Apr; 325(1):331-40. PubMed ID: 18171907
[TBL] [Abstract][Full Text] [Related]
34. Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction.
Mishra A; Kumar B; Dutta V; Arya VK; Mishra AK
J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):639-46. PubMed ID: 27321790
[TBL] [Abstract][Full Text] [Related]
35. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery.
Erb J; Beutlhauser T; Feldheiser A; Schuster B; Treskatsch S; Grubitzsch H; Spies C
J Int Med Res; 2014 Jun; 42(3):750-64. PubMed ID: 24781725
[TBL] [Abstract][Full Text] [Related]
36. Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass grafting.
Akgul A; Mavioglu L; Katircioglu SF; Pac M; Cobanoglu A
Heart Lung Circ; 2006 Oct; 15(5):320-4. PubMed ID: 16860605
[TBL] [Abstract][Full Text] [Related]
37. Levosimendan compared with dobutamine in low output patients.
Nieminen MS
Minerva Anestesiol; 2003 Apr; 69(4):258-63. PubMed ID: 12766717
[TBL] [Abstract][Full Text] [Related]
38. Management of acute cardiac failure by intracoronary administration of levosimendan.
Caimmi PP; Kapetanakis EI; Beggino C; Molinari C; Giustini G; Crosio E; Reposo G; Micalizzi E; Vacca G; Grossini E
J Cardiovasc Pharmacol; 2011 Sep; 58(3):246-53. PubMed ID: 21654504
[TBL] [Abstract][Full Text] [Related]
39. Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial.
Momeni M; Rubay J; Matta A; Rennotte MT; Veyckemans F; Poncelet AJ; Clement de Clety S; Anslot C; Joomye R; Detaille T
J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):419-24. PubMed ID: 20829069
[TBL] [Abstract][Full Text] [Related]
40. Effect of levosimendan and milrinone on regional myocardial ischemia/reperfusion-induced arrhythmias in dogs.
Papp JG; Pollesello P; Varró AF; Végh AS
J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):129-35. PubMed ID: 16891290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
